GPT and acute lymphoblastic leukemia: The hepatoprotective effect of silymarin was documented by a slight significant decrease in serum levels of ALT, AST, GGT and bilirubin in the silymarin-treatment group compared with the placebo group in ALL patients (p < 0.05, Figure 2).